Associated Medical Conditions for Autism

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Allergies 26 % 30% 13 50 110
Ankylosing spondylitis 35.5 % 7% 39 520 110
Alzheimer's disease 40 % 10% 20 50 110
Ulcerative colitis 25 % 0.1% 27 108 110
Rosacea 45.5 % 5.46% 10 22 110
Schizophrenia 31.2 % 0.75% 29 93 110
Multiple Sclerosis 31 % 0.5% 31 100 110
Mood Disorders 33.3 % 29.7% 2 6 110
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 31.8 % 0.86% 35 134 110
Psoriasis 41.3 % 3% 19 46 110
Obesity 32.7 % 42.4% 18 55 110
Obesity 21.2 % 42.4% 22 104 110
Amyotrophic lateral sclerosis (ALS) Motor Neuron 39.5 % 0.005% 17 43 110
Osteoporosis 40.9 % 9.4% 9 22 110
neuropsychiatric disorders (PANDAS, PANS) 46.7 % 0.1% 7 15 110
ME/CFS with IBS 31.6 % 2.8% 6 19 110
ME/CFS without IBS 19.2 % 0.4% 5 26 110
Multiple system atrophy (MSA) 28.6 % 0.005% 6 21 110
Metabolic Syndrome 42.9 % 21% 3 7 110
Systemic Lupus Erythematosus 31.8 % 0.15% 21 66 110
Liver Cirrhosis 52.7 % 0.27% 58 678 110
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 28.9 % 25% 22 76 110
Parkinson's Disease 31.1 % 1% 28 90 110
Chronic Kidney Disease 45.7 % 15% 16 35 110
Insomnia 40 % 30% 4 10 110
Depression 33.3 % 8% 27 81 110
Irritable Bowel Syndrome 32.3 % 15% 20 62 110
Chronic Urticaria (Hives) 39.1 % 5% 9 23 110
IgA nephropathy (IgAN) 41.4 % 0.001% 12 29 110
Hyperlipidemia (High Blood Fats) 24 % 33% 6 25 110
hypertension (High Blood Pressure 50 % 47% 3 6 110
hypercholesterolemia (High Cholesterol) 44.4 % 12% 4 9 110
Allergic Rhinitis (Hay Fever) 22.2 % 7.8% 8 36 110
gallstone disease (gsd) 66.7 % 5% 10 15 110
Graves' disease 37.5 % 0.5% 3 8 110
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 25 % 27.8% 6 24 110
Fibromyalgia 43.2 % 1.12% 16 37 110
Functional constipation / chronic idiopathic constipation 43.9 % 14% 18 41 110
Type 1 Diabetes 32.7 % 0.19% 17 52 110
Gout 19 % 6.8% 4 21 110
Epilepsy 36 % 0.84% 9 25 110
Cerebral Palsy 58.8 % 0.2% 10 17 110
Inflammatory Bowel Disease 40.9 % 1.3% 27 66 110
Celiac Disease 35.8 % 1.4% 24 67 110
COVID-19 16.7 % 50% 6 36 110
Carcinoma 35.3 % 1% 18 51 110
Bipolar Disorder 36.4 % 3% 12 33 110
Colorectal Cancer 22.7 % 4.3% 25 296 110
Chronic Fatigue Syndrome 29.1 % 3% 16 55 110
Coronary artery disease 37.5 % 6.7% 6 16 110
Crohn's Disease 40 % 0.3% 44 141 110
Barrett esophagus cancer 31.3 % 7% 5 16 110
Generalized anxiety disorder 21.4 % 2.7% 3 14 110
Asthma 33.3 % 8% 9 27 110
Atherosclerosis 38.2 % 50% 42 524 110
Acne 36.8 % 47% 7 19 110
Stress / posttraumatic stress disorder 37.5 % 5.2% 21 56 110
Small Intestinal Bacterial Overgrowth (SIBO) 25 % 52% 4 16 110
Brain Trauma 59.1 % 0.367% 13 22 110
Sjögren syndrome 43.9 % 1.2% 18 41 110
Type 2 Diabetes 55.5 % 10.8% 61 267 110
ADHD 31.9 % 9.4% 15 47 110
Hashimoto's thyroiditis 50 % 0.35% 7 14 110

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.